Guild Investment Management, Inc. Astrazeneca PLC Transaction History

Guild Investment Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$48.42 - $60.18 $2.28 Million - $2.83 Million	-47,055 Closed	0 $0
Q1 2021 Apr 19, 2021	BUY	$47.16 - $54.44 $279,894 - $323,101	5,935 Added 14.43%	47,055 $2.34 Million
Q4 2020 Jan 14, 2021	BUY	$48.52 - $58.02 $1.07 Million - $1.27 Million	21,950 Added 114.5%	41,120 $2.06 Million
Q3 2020 Oct 13, 2020	SELL	$53.07 - $61.1 $97,118 - $111,813	-1,830 Reduced 8.71%	19,170 $1.05 Million
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $46,117 - $59,181	1,070 Added 5.37%	21,000 $1.11 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $92,585 - $125,758	-2,450 Reduced 10.95%	19,930 $890,000
Q4 2019 Feb 06, 2020	BUY	$42.46 - $50.46 $950,254 - $1.13 Million	22,380 New	22,380 $1.12 Million

1,333

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $244B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Guild Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Guild Investment Management, Inc. with notifications on news.